Squarepoint’s PRA Health Sciences, Inc. PRAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-223,353
Closed -$36.9M 3752
2021
Q2
$36.9M Buy
223,353
+196,025
+717% +$32.7M 0.14% 141
2021
Q1
$4.19M Buy
27,328
+2,705
+11% +$367K 0.02% 709
2020
Q4
$3.09M Sell
24,623
-19,082
-44% -$2.13M 0.02% 704
2020
Q3
$4.43M Buy
43,705
+10,404
+31% +$1.06M 0.06% 376
2020
Q2
$3.24M Buy
33,301
+11,558
+53% +$1.08M 0.05% 474
2020
Q1
$1.81M Sell
21,743
-41,270
-65% -$4.02M 0.05% 479
2019
Q4
$7M Buy
63,013
+36,900
+141% +$3.8M 0.04% 395
2019
Q3
$2.59M Sell
26,113
-37,806
-59% -$3.75M 0.02% 741
2019
Q2
$6.34M Sell
63,919
-40,703
-39% -$3.88M 0.06% 364
2019
Q1
$11.5M Buy
104,622
+57,932
+124% +$6.05M 0.12% 203
2018
Q4
$4.29M Buy
46,690
+38,134
+446% +$3.86M 0.05% 448
2018
Q3
$943K Sell
8,556
-120,188
-93% -$12.5M 0.01% 1021
2018
Q2
$12M Buy
128,744
+123,144
+2,199% +$10.6M 0.16% 184
2018
Q1
$465K Sell
5,600
-10,505
-65% -$933K 0.01% 1118
2017
Q4
$1.47M Buy
16,105
+13,045
+426% +$1.09M 0.03% 663
2017
Q3
$233K Sell
3,060
-5,629
-65% -$425K ﹤0.01% 1311
2017
Q2
$652K Sell
8,689
-8,705
-50% -$603K 0.01% 859
2017
Q1
$1.14M Buy
17,394
+10,413
+149% +$613K 0.03% 560
2016
Q4
$385K Sell
6,981
-6,922
-50% -$380K 0.02% 983
2016
Q3
$786K Sell
13,903
-5,645
-29% -$277K 0.05% 420
2016
Q2
$816K Buy
19,548
+13,448
+220% +$620K 0.05% 417
2016
Q1
$261K Buy
+6,100
New +$258K 0.02% 881

Other funds holding PRAH

Squarepoint's PRAH Position: Q3 2021 in Review

Squarepoint sold out of PRA Health Sciences, Inc. (PRAH) in Q3 2021, closing a stake of 223,353 shares — an estimated $36.9M sold.

Squarepoint first reported a position in PRAH in Q1 2016 and held it in 22 quarters. The position peaked at $36.9M in Q2 2021. 1 fund tracked by Wall St. Rank holds PRAH as of Q3 2021.

  • Squarepoint reported no remaining PRA Health Sciences, Inc. position as of Q3 2021 after selling out during the quarter.
  • Squarepoint sold 223,353 PRA Health Sciences, Inc. shares in Q3 2021, an estimated $36.9M.
  • Squarepoint first reported a position in PRA Health Sciences, Inc. in Q1 2016 and held it in 22 quarters.
  • Squarepoint's PRA Health Sciences, Inc. position peaked at $36.9M in Q2 2021.
  • 1 fund tracked by Wall St. Rank held PRA Health Sciences, Inc. as of Q3 2021.

Based on Squarepoint's 13F filing for Q3 2021, filed 15 Nov 2021.